Send to

Choose Destination
Bioengineered. 2017 Jan 2;8(1):29-35. Epub 2016 Sep 30.

Thrombolysis based on magnetically-controlled surface-functionalized Fe3O4 nanoparticle.

Author information

a College of Mechanical Engineering and Automation , Huaqiao University , Xiamen, Fujian , China.
b Department of Mechanical Engineering , Chung Yuan Christian University , Chung Li , Taiwan.
c Mapua Institute of Technology , Intramuros, Manila , Philippines.
d The State Key Laboratory of Digital Manufacturing Equipment and Technology , Huazhong University of Science and Technology , Wuhan , China.


In this study, the control of magnetic fields to manipulate surface-functionalized Fe3O4 nanoparticles by urokinase coating is investigated for thrombolysis in a microfluidic channel. The urokinase-coated Fe3O4 nanoparticles are characterized using particle size distribution, zeta potential measurement and spectroscopic data. Thrombolytic ratio tests reveal that the efficiency for thrombus cleaning is significantly improved when using magnetically-controlled urokinase-coated Fe3O4 nanoparticles than pure urokinase solution. The average increase in the rate of thrombolysis with the use of urokinase-coated Fe3O4 nanoparticles is about 50%. In vitro thrombolysis test in a microfluidic channel using the coated nanoparticles shows nearly complete removal of thrombus, a result that can be attributed to the clot busting effect of the urokinase as it inhibits the possible formation of blood bolus during the magnetically-activated microablation process. The experiment further demonstrates that a thrombus mass of 10.32 mg in the microchannel is fully removed in about 180 s.


Fe3O4 nanoparticles; magnetic-control; magnetically-activated microablation; surface-functionalized; thrombolysis; urokinase

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center